ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
CTSNet Summarized—Top JANS Articles of 2024
Over the past year, CTSNet JANS editors have done an excellent job at gathering relevant and compelling news in cardiothoracic surgery, covering topics such as multiarterial versus single-arterial coronary surgery and transcatheter or surgical treatment of aortic valve stenosis. Continue exploring the top JANS articles in 2024 and expect more informative, useful content in 2025.
1.) Multiarterial vs Single-Arterial Coronary Surgery: Ten-Year Follow-Up of One Million Patients
The most popular JANS article this year examines the long-term survival of patients undergoing multiarterial grafting (MAG) versus single-arterial grafting (SAG) in coronary artery bypass grafting (CABG).
Another popular JANS article this year examines the critical role of proximal anastomosis in coronary artery bypass grafting (CABG), highlighting its impact on the risk of perioperative stroke. Key points include the importance of thorough preoperative assessments, particularly using CT scans to evaluate ascending aorta calcification, a known risk factor for stroke.
This highly rated JANS article is a population-based cohort study that examined midterm outcomes of surgical aortic valve replacement with mechanical or bioprosthetic valves in patients less than 50 years old.
4.) Cardiac Surgery After Transcatheter Aortic Valve Replacement: Trends and Outcomes
Next, is a report that presents trends and outcomes of cardiac surgery following initial transcatheter aortic valve replacement (TAVR).
5.) Transcatheter or Surgical Treatment of Aortic Valve Stenosis
Finally, this article examined a nonindustry sponsored randomized noninferiority trial conducted at 38 sites in Germany, where patients with severe aortic stenosis who were at low or intermediate surgical risk were randomly assigned to undergo either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR). TAVI and SAVR prostheses were selected at the operator's discretion
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
